Clinical response to bevacizumab in schwannomatosis. uri icon

Overview

publication date

  • October 22, 2014

Research

keywords

  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal, Humanized
  • Neurilemmoma
  • Neurofibromatoses
  • Skin Neoplasms

Identity

PubMed Central ID

  • PMC4248457

Scopus Document Identifier

  • 84961291574

Digital Object Identifier (DOI)

  • 10.1212/WNL.0000000000000997

PubMed ID

  • 25339217

Additional Document Info

volume

  • 83

issue

  • 21